the US FDA’s Emergency Use Authorization for the Amplitude™ Solution
The FDA has issued emergency use authorization for Thermo Fisher Scientific’s Amplitude Solution. “We are grateful for our partners and have scaled resources to bring supplies that you need,” says Mark Stevenson, Executive Vice President and Chief Operating Officer at Thermo Fisher Scientific, the world’s leader in serving science.
The Amplitude™ Solution brings a dynamic and world-class COVID-19 testing system to labs to test between 1,000 and 8,000 samples per day with minimal laboratory resources and 24/7 dedicated support. According to Mr. Stevenson, Amplitude is critically important in the next phase of the ongoing fight against COVID-19 as many resume pre-COVID behaviors and practices. One of the ways to help manage the re-opening of the world’s economies will be through comprehensive testing for COVID-19. The SARS-CoV-2 virus is pervasive and elusive, and we may witness upcoming waves during the fall flu season, with the on-going emergence of mutations and other seasonal respiratory diseases. For these reasons, we continue to scale our innovations around responding to this crisis and helping you meet your clinical testing needs.
Thank you for your partnership and extraordinary commitment to clinical excellence.